Endpoints used in phase III randomized controlled trials of treatment options for COVID-19

被引：20
|
作者：
Desai, Aakash [1 ]
Gyawali, Bishal [2 ,3 ,4 ]
机构：
[1] Univ Connecticut, Dept Med, Farmington, CT 06030 USA
[2] Queens Univ, Dept Oncol, Kingston, ON, Canada
[3] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada
[4] Queens Univ, Div Canc Care & Epidemiol, Kingston, ON, Canada
来源：
ECLINICALMEDICINE | 2020年 / 23卷
关键词：
D O I：
10.1016/j.eclinm.2020.100403
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Endpoints for randomized controlled clinical trials for COVID-19 treatments
    Dodd, Lori E.
    Follmann, Dean
    Wang, Jing
    Koenig, Franz
    Korn, Lisa L.
    Schoergenhofer, Christian
    Proschan, Michael
    Hunsberger, Sally
    Bonnett, Tyler
    Makowski, Mat
    Belhadi, Drifa
    Wang, Yeming
    Bin Cao
    Mentre, France
    Jaki, Thomas
    [J]. CLINICAL TRIALS, 2020, 17 (05) : 472 - 482
  • [2] Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov
    Sakamaki, Kentaro
    Uemura, Yukari
    Shimizu, Yosuke
    [J]. TRIALS, 2021, 22 (01)
  • [3] Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov
    Kentaro Sakamaki
    Yukari Uemura
    Yosuke Shimizu
    [J]. Trials, 22
  • [4] Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials
    Horowitz, Richard, I
    Freeman, Phyllis R.
    [J]. MEDICAL HYPOTHESES, 2020, 143
  • [5] COVID-19 randomized controlled trials in medRxiv and PubMed
    Kataoka, Yuki
    Oide, Shiho
    Ariie, Takashi
    Tsujimoto, Yasushi
    Furukawa, Toshi A.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 81
  • [6] Antiviral Treatment in COVID-19 Outpatients: A Systematic Review of Randomized Controlled Trials
    Budi, David Setyo
    Oktavian, Puguh
    Asmarawati, Tri Pudy
    Lestari, Pudji
    Ariviani, Fauziah
    Ihsanulhaj, Raka
    Tsania, Tamara
    Febiola, Danise
    Putri, Naomi Lesmana
    [J]. ACTA MEDICA INDONESIANA, 2022, 54 (04) : 540 - 555
  • [7] REMDESIVIR FOR THE TREATMENT OF COVID-19: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Musa, Arif
    Warbasse, Elizabeth
    Yousif, Jenna
    Baron, David
    Stevens, Susan
    Blodget, Emily
    Pendi, Kasim
    Hashemi, Areio
    Aly, Besma
    Khambati, Alisha
    Tajran, Jahan
    Paradela, Danielle Rangel
    Chen, Daniel H.
    Kamal, Khalid
    Kouyoumjian, Sarkis
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S157 - S158
  • [8] Antiandrogens for the treatment of COVID-19 patients: A meta-analysis of randomized controlled trials
    Cheema, Huzaifa Ahmad
    Rehman, Aqeeb Ur
    Elrashedy, Asmaa Ahmed
    Mohsin, Aleenah
    Shahid, Abia
    Ehsan, Muhammad
    Ayyan, Muhammad
    Ismail, Heba
    Almas, Talal
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)
  • [9] Curcumin for the treatment of COVID-19 patients: A meta-analysis of randomized controlled trials
    Shafiee, Arman
    Athar, Mohammad Mobin Teymouri
    Shahid, Abia
    Ghafoor, Muhammad Saqib
    Ayyan, Muhammad
    Zahid, Afra
    Cheema, Huzaifa Ahmad
    [J]. PHYTOTHERAPY RESEARCH, 2023, 37 (03) : 1167 - 1175
  • [10] Nocebo responses in randomized controlled trials of COVID-19 vaccines
    Lee, Young Ho
    Song, Gwan Gyu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2022, 60 (01) : 5 - 12
12345